Scientist
Manifold Bio
Scientist
Manifold Bio
In vivo precision biologics design platform
Position
We are seeking a PhD-level scientist to run preclinical pharmacology and target validation studies for our neuroscience and metabolic programs, with a focus on siRNA and oligonucleotide therapeutics. This is a hands-on lab role. You will execute vivo studies, run the downstream assays that show whether a target is engaged and a therapeutic is working, and turn that data into clear answers for the team. Our work centers on neurodegenerative diseases, obesity and cardiometabolic disease across adipose, liver, and heart, with some programs touching the neural regulation of energy balance
You’ll join a team that moves with the speed and conviction of a biotech, working closely with discovery, translational, and external partners to advance novel therapeutics. We will consider candidates at the Scientist or Senior Scientist level, depending on experience.
Responsibilities
Technical Expertise
Required Qualifications
Preferred Qualifications
Base Salary Range: $120,000-$160,000
This reflects the typical offer range for this role, based on experience, role scope, and internal equity. Final compensation decisions are made using a consistent leveling framework and consider the candidate’s experience, interview performance, and expected impact.
This role is eligible for:
Our compensation ranges are reviewed annually to ensure alignment with market trends and internal equity.
We value different experiences and ways of thinking and believe the most talented teams are built by bringing together people of diverse cultures, genders, and backgrounds.
In vivo precision biologics design platform
Manifold Bio creates precision biologics by designing drugs inside living organisms. Its in vivo drug design platform uses a proprietary mCodes protein barcoding system to multiplex multiple proteins in one experiment, enabling pooled in vivo testing of complex biologics. This makes it easier to study and optimize large, biologic drugs in a living system rather than in a test tube. The company differentiates itself as the first to offer an in vivo design platform powered by protein barcodes, allowing researchers to test many proteins at once and streamline drug discovery for complex biologics. Its goal is to expand its in vivo design platform and license or partner its technology with other pharmaceutical and biotech companies to develop new therapeutics.
Explore more opportunities at Manifold Bio